$7.1 Billion is the total value of Redmile Group, LLC's 86 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 40.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FATE | Buy | FATE THERAPEUTICS INC | $1,068,323,000 | -7.0% | 12,957,222 | +2.6% | 15.05% | +8.2% |
| ALLK | Sell | ALLAKOS INC | $277,701,000 | -25.6% | 2,419,418 | -9.3% | 3.91% | -13.5% |
| IGMS | IGM BIOSCIENCES INC | $262,698,000 | -13.1% | 3,425,455 | 0.0% | 3.70% | +1.0% | |
| ARGX | Sell | ARGENX SEsponsored adr | $234,039,000 | -13.3% | 849,845 | -7.5% | 3.30% | +0.8% |
| FOLD | Buy | AMICUS THERAPEUTICS INC | $208,607,000 | -56.2% | 21,114,114 | +2.4% | 2.94% | -49.0% |
| BEAM | Sell | BEAM THERAPEUTICS INC | $202,703,000 | -34.3% | 2,532,523 | -33.0% | 2.86% | -23.6% |
| DCPH | Sell | DECIPHERA PHARMACEUTICALS IN | $195,128,000 | -23.0% | 4,351,644 | -1.9% | 2.75% | -10.4% |
| NVTA | Sell | INVITAE CORP | $185,401,000 | -15.7% | 4,852,163 | -7.8% | 2.61% | -2.0% |
| ADCT | Buy | ADC THERAPEUTICS SA | $178,398,000 | -17.5% | 7,308,418 | +8.1% | 2.51% | -4.1% |
| STTK | SHATTUCK LABS INC | $164,326,000 | -44.2% | 5,619,914 | 0.0% | 2.32% | -35.1% | |
| MDVL | MEDAVAIL HOLDINGS INC | $164,146,000 | -7.0% | 11,724,726 | 0.0% | 2.31% | +8.2% | |
| OSH | Buy | OAK STR HEALTH INC | $159,033,000 | -11.1% | 2,930,411 | +0.2% | 2.24% | +3.4% |
| KRYS | Buy | KRYSTAL BIOTECH INC | $158,713,000 | +57.9% | 2,060,132 | +23.0% | 2.24% | +83.6% |
| JAZZ | New | JAZZ PHARMACEUTICALS PLC | $136,289,000 | – | 829,159 | +100.0% | 1.92% | – |
| SGEN | New | SEAGEN INC | $130,118,000 | – | 937,045 | +100.0% | 1.83% | – |
| PLRX | Sell | PLIANT THERAPEUTICS INC | $126,139,000 | +63.9% | 3,207,193 | -5.3% | 1.78% | +90.7% |
| REPL | Buy | REPLIMUNE GROUP INC | $125,647,000 | -17.5% | 4,118,212 | +3.1% | 1.77% | -4.1% |
| MDT | New | MEDTRONIC PLC | $115,662,000 | – | 979,108 | +100.0% | 1.63% | – |
| SRRK | Sell | SCHOLAR ROCK HLDG CORP | $110,268,000 | -21.6% | 2,176,628 | -24.9% | 1.55% | -8.8% |
| NRIX | Buy | NURIX THERAPEUTICS INC | $103,036,000 | +10.1% | 3,314,117 | +16.4% | 1.45% | +28.1% |
| KYMR | Sell | KYMERA THERAPEUTICS INC | $101,158,000 | -40.0% | 2,603,139 | -4.3% | 1.42% | -30.2% |
| ATRA | Buy | ATARA BIOTHERAPEUTICS INC | $98,872,000 | -26.6% | 6,885,233 | +0.3% | 1.39% | -14.6% |
| STOK | Sell | STOKE THERAPEUTICS INC | $98,811,000 | -40.6% | 2,544,062 | -5.3% | 1.39% | -30.9% |
| ZNTL | Sell | ZENTALIS PHARMACEUTICALS INC | $96,371,000 | -23.2% | 2,221,044 | -8.1% | 1.36% | -10.7% |
| ANNX | Buy | ANNEXON INC | $96,294,000 | +11.6% | 3,458,830 | +0.3% | 1.36% | +29.8% |
| GNMK | Sell | GENMARK DIAGNOSTICS INC | $85,785,000 | +29.5% | 3,589,342 | -20.9% | 1.21% | +50.6% |
| LIVN | New | LIVANOVA PLC | $82,565,000 | – | 1,119,830 | +100.0% | 1.16% | – |
| RPTX | Buy | REPARE THERAPEUTICS INC | $81,804,000 | -9.9% | 2,665,496 | +0.7% | 1.15% | +4.7% |
| NGM | New | NGM BIOPHARMACEUTICALS INC | $79,995,000 | – | 2,751,815 | +100.0% | 1.13% | – |
| DXCM | New | DEXCOM INC | $79,949,000 | – | 222,458 | +100.0% | 1.13% | – |
| RGNX | Buy | REGENXBIO INC | $79,828,000 | -17.1% | 2,340,313 | +10.2% | 1.12% | -3.6% |
| TCRR | Buy | TCR2 THERAPEUTICS INC | $79,726,000 | -9.0% | 3,610,788 | +27.5% | 1.12% | +5.8% |
| IMGN | Sell | IMMUNOGEN INC | $78,473,000 | +15.6% | 9,688,066 | -8.0% | 1.10% | +34.4% |
| EPZM | Sell | EPIZYME INC | $76,860,000 | -25.1% | 8,824,366 | -6.6% | 1.08% | -12.9% |
| AKRO | Buy | AKERO THERAPEUTICS INC | $72,924,000 | +21.7% | 2,513,746 | +8.2% | 1.03% | +41.5% |
| ALXO | Buy | ALX ONCOLOGY HLDGS INC | $72,162,000 | -12.8% | 978,600 | +1.9% | 1.02% | +1.4% |
| NVRO | Buy | NEVRO CORP | $72,093,000 | -6.2% | 516,795 | +16.4% | 1.02% | +9.1% |
| AVIR | Sell | ATEA PHARMACEUTICALS INC | $71,512,000 | -23.3% | 1,158,082 | -48.1% | 1.01% | -10.8% |
| CLDX | Buy | CELLDEX THERAPEUTICS INC NEW | $69,788,000 | +46.9% | 3,387,788 | +24.9% | 0.98% | +71.0% |
| CI | Sell | CIGNA CORP NEW | $67,701,000 | -15.1% | 280,057 | -26.9% | 0.95% | -1.2% |
| SLQT | Buy | SELECTQUOTE INC | $59,169,000 | +54.6% | 2,005,054 | +8.7% | 0.83% | +79.9% |
| NLTX | Sell | NEOLEUKIN THERAPEUTICS INC | $50,687,000 | -13.0% | 4,117,569 | -0.3% | 0.71% | +1.3% |
| CRL | New | CHARLES RIV LABS INTL INC | $48,309,000 | – | 166,679 | +100.0% | 0.68% | – |
| NUVB | New | NUVATION BIO INC | $47,454,000 | – | 4,541,009 | +100.0% | 0.67% | – |
| ANTM | Sell | ANTHEM INC | $46,809,000 | -40.3% | 130,405 | -46.6% | 0.66% | -30.6% |
| PRTA | New | PROTHENA CORP PLC | $46,650,000 | – | 1,857,072 | +100.0% | 0.66% | – |
| ICUI | Sell | ICU MED INC | $46,050,000 | -11.1% | 224,154 | -7.2% | 0.65% | +3.5% |
| BIIB | Sell | BIOGEN INC | $45,556,000 | -14.0% | 162,847 | -24.7% | 0.64% | +0.2% |
| ALVR | Sell | ALLOVIR INC | $45,480,000 | -49.1% | 1,943,587 | -16.4% | 0.64% | -40.8% |
| GMAB | New | GENMAB A/Ssponsored ads | $43,737,000 | – | 1,332,212 | +100.0% | 0.62% | – |
| LVTX | New | LAVA THERAPEUTICS NV | $42,903,000 | – | 2,824,409 | +100.0% | 0.60% | – |
| UNH | Sell | UNITEDHEALTH GROUP INC | $42,556,000 | -46.0% | 114,376 | -49.1% | 0.60% | -37.2% |
| BCEL | Buy | ATRECA INC | $38,180,000 | -4.5% | 2,490,568 | +0.6% | 0.54% | +11.2% |
| AMED | Sell | AMEDISYS INC | $35,212,000 | -10.1% | 132,980 | -0.4% | 0.50% | +4.6% |
| ACHL | New | ACHILLES THERAPEUTICS PLCsponsored ads | $34,558,000 | – | 2,088,089 | +100.0% | 0.49% | – |
| RCEL | Sell | AVITA MEDICAL INC | $33,066,000 | +4.2% | 1,668,327 | -2.3% | 0.47% | +21.4% |
| CTLT | Sell | CATALENT INC | $32,817,000 | +0.3% | 311,619 | -0.9% | 0.46% | +16.7% |
| PPD | Sell | PPD INC | $31,070,000 | +10.3% | 821,092 | -0.3% | 0.44% | +28.4% |
| ZYME | Sell | ZYMEWORKS INC | $31,128,000 | -39.5% | 985,700 | -9.4% | 0.44% | -29.7% |
| HOOK | HOOKIPA PHARMA INC | $24,787,000 | +21.3% | 1,842,902 | 0.0% | 0.35% | +41.3% | |
| IMTX | Buy | IMMATICS N.V | $23,348,000 | +4.6% | 2,082,814 | +0.7% | 0.33% | +21.9% |
| ARDX | ARDELYX INC | $23,263,000 | +2.3% | 3,514,100 | 0.0% | 0.33% | +19.3% | |
| GRTS | Sell | GRITSTONE ONCOLOGY INC | $23,086,000 | +91.5% | 2,448,158 | -20.0% | 0.32% | +122.6% |
| BVS | New | BIOVENTUS INC | $22,920,000 | – | 1,500,000 | +100.0% | 0.32% | – |
| ONEM | Sell | 1LIFE HEALTHCARE INC | $21,975,000 | -84.8% | 562,314 | -83.0% | 0.31% | -82.3% |
| ITMR | Buy | ITAMAR MED LTDsponsored ads | $22,008,000 | +55.8% | 918,900 | +29.1% | 0.31% | +81.3% |
| INNV | New | INNOVAGE HLDG CORP | $21,922,000 | – | 850,000 | +100.0% | 0.31% | – |
| STXS | Buy | STEREOTAXIS INC | $21,784,000 | +37.9% | 3,241,603 | +4.5% | 0.31% | +60.7% |
| VSPR | Buy | VESPER HEALTHCARE ACQSTN COR | $21,414,000 | +89.3% | 1,982,749 | +98.3% | 0.30% | +120.4% |
| CTSO | Buy | CYTOSORBENTS CORP | $18,468,000 | +12.8% | 2,127,631 | +3.6% | 0.26% | +31.3% |
| QTRX | New | QUANTERIX CORP | $17,541,000 | – | 300,000 | +100.0% | 0.25% | – |
| PROF | Buy | PROFOUND MED CORP | $17,032,000 | +0.4% | 845,674 | +2.5% | 0.24% | +17.1% |
| YMTX | YUMANITY THERAPEUTICS INC | $11,059,000 | +6.5% | 611,003 | 0.0% | 0.16% | +23.8% | |
| QURE | Sell | UNIQURE NV | $9,573,000 | -74.2% | 284,160 | -72.4% | 0.14% | -70.0% |
| DVAX | Sell | DYNAVAX TECHNOLOGIES CORP | $8,678,000 | +60.3% | 882,814 | -27.5% | 0.12% | +84.8% |
| XERS | Sell | XERIS PHARMACEUTICALS INC | $7,722,000 | -34.5% | 1,712,304 | -28.6% | 0.11% | -23.8% |
| CABA | Sell | CABALETTA BIO INC | $7,730,000 | -55.1% | 696,378 | -49.5% | 0.11% | -47.6% |
| AYLA | AYALA PHARMACEUTICALS INC | $7,286,000 | -4.2% | 667,816 | 0.0% | 0.10% | +12.0% | |
| STIM | New | NEURONETICS INC | $6,185,000 | – | 500,000 | +100.0% | 0.09% | – |
| TLIS | New | TALIS BIOMEDICAL CORP | $5,140,000 | – | 400,000 | +100.0% | 0.07% | – |
| APRE | Sell | APREA THERAPEUTICS INC | $3,544,000 | -43.2% | 694,918 | -45.2% | 0.05% | -34.2% |
| SYRS | SYROS PHARMACEUTICALS INC | $1,588,000 | -31.0% | 212,291 | 0.0% | 0.02% | -21.4% | |
| OVID | OVID THERAPEUTICS INC | $490,000 | +73.8% | 121,950 | 0.0% | 0.01% | +133.3% | |
| WVE | WAVE LIFE SCIENCES LTD | $443,000 | -28.8% | 79,018 | 0.0% | 0.01% | -25.0% | |
| TCDA | Sell | TRICIDA INC | $290,000 | -90.9% | 54,758 | -87.9% | 0.00% | -89.7% |
| CSLT | CASTLIGHT HEALTH INCcl b | $15,000 | +15.4% | 10,229 | 0.0% | 0.00% | – | |
| VAPO | Exit | VAPOTHERM INC | $0 | – | -25,000 | -100.0% | -0.01% | – |
| RIGL | Exit | RIGEL PHARMACEUTICALS INC | $0 | – | -744,582 | -100.0% | -0.03% | – |
| OM | Exit | OUTSET MED INC | $0 | – | -70,000 | -100.0% | -0.05% | – |
| MASS | Exit | 908 DEVICES INC | $0 | – | -75,000 | -100.0% | -0.05% | – |
| EAR | Exit | EARGO INC | $0 | – | -129,488 | -100.0% | -0.07% | – |
| SEER | Exit | SEER INC | $0 | – | -125,000 | -100.0% | -0.08% | – |
| LUNG | Exit | PULMONX CORP | $0 | – | -275,000 | -100.0% | -0.23% | – |
| ABCL | Exit | ABCELLERA BIOLOGICS INC | $0 | – | -500,000 | -100.0% | -0.24% | – |
| PAND | Exit | PANDION THERAPEUTICS INC | $0 | – | -1,398,705 | -100.0% | -0.25% | – |
| CNC | Exit | CENTENE CORP DEL | $0 | – | -554,962 | -100.0% | -0.40% | – |
| PRAH | Exit | PRA HEALTH SCIENCES INC | $0 | – | -265,736 | -100.0% | -0.40% | – |
| UBER | Exit | UBER TECHNOLOGIES INC | $0 | – | -833,845 | -100.0% | -0.52% | – |
| BNTX | Exit | BIONTECH SEsponsored ads | $0 | – | -580,746 | -100.0% | -0.57% | – |
| EIDX | Exit | EIDOS THERAPEUTICS INC | $0 | – | -452,295 | -100.0% | -0.72% | – |
| GWPH | Exit | GW PHARMACEUTICALS PLCads | $0 | – | -815,681 | -100.0% | -1.14% | – |
| SNY | Exit | SANOFIsponsored adr | $0 | – | -1,984,690 | -100.0% | -1.17% | – |
| GILD | Exit | GILEAD SCIENCES INC | $0 | – | -2,288,846 | -100.0% | -1.62% | – |
| ABBV | Exit | ABBVIE INC | $0 | – | -1,388,904 | -100.0% | -1.80% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-17
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMICUS THERAPEUTICS INC | 43 | Q3 2023 | 10.1% |
| ATARA BIOTHERAPEUTICS INC | 36 | Q3 2023 | 6.4% |
| FATE THERAPEUTICS INC | 34 | Q3 2023 | 17.2% |
| INVITAE CORP | 32 | Q3 2023 | 2.7% |
| REGENXBIO INC | 28 | Q3 2023 | 3.8% |
| CLOVIS ONCOLOGY INC | 27 | Q1 2020 | 6.7% |
| IMMUNOGEN INC | 27 | Q3 2023 | 13.2% |
| CASTLIGHT HEALTH INC SAN FRAN COM STK | 27 | Q1 2021 | 2.5% |
| ARRAY BIOPHARMA INC | 26 | Q2 2019 | 12.6% |
| DECIPHERA PHARMACEUTICALS IN | 25 | Q3 2023 | 7.0% |
View Redmile Group, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Neoleukin Therapeutics, Inc. | July 27, 2023 | 2,912,228 | 6.6% |
| IGM Biosciences, Inc. | June 28, 2023 | 3,291,092 | 9.9% |
| MedAvail Holdings, Inc. | June 21, 2023 | 124,507,268 | 73.1% |
| Achilles Therapeutics plc | February 14, 2023 | 1,608,089 | 3.9% |
| Kymera Therapeutics, Inc. | February 14, 2023 | 2,673,837 | 4.9% |
| Old Ayala, IncSold out | February 08, 2023 | 0 | 0.0% |
| Zymeworks Inc. | August 08, 2022 | 5,758,241 | 9.9% |
| Science 37 Holdings, Inc. | June 15, 2022 | 19,808,234 | 17.1% |
| Allakos Inc. | February 14, 2022 | 2,077,875 | 3.8% |
| Aprea Therapeutics, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
View Redmile Group, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-01 |
| 4 | 2024-04-01 |
| 4 | 2024-03-25 |
| SC 13D/A | 2024-03-25 |
| 4 | 2024-03-19 |
| 4 | 2024-03-14 |
| 4 | 2024-03-13 |
| SC 13D/A | 2024-03-13 |
| 4 | 2024-03-05 |
| SC 13D/A | 2024-03-05 |
View Redmile Group, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.